Unigen and Science Based Ingredients (SBI) Collaborate on Novel Ingredients Distribution to Canadian Nutraceutical Market

TACOMA, WASHINGTON – November 7, 2024: Unigen Inc., a natural product R&D ingredient supplier, is pleased to announce its strategic partnership with Science Based Ingredients (Ontario, CANADA). SBI has been appointed exclusive distributor for Unigen’s clinically proven, botanical sleep support and joint health ingredients Maizinol® and Univestin®.

Unigen’s nutraceutical pipeline of novel ingredients is backed by extensive scientific research and focuses on current consumer needs for sleep, joint & cartilage health, mood & stress, immunity, cognitive, metabolism and liver health. Unigen recently announced clinical trial results from a second sleep study on Maizinol® that yielded statistically-significant results on critical components of sleep quality and structure. Univestin® is a natural joint-care ingredient clinically proven to support joint comfort, enhance flexibility and support mobility. In addition to its nutraceutical line, Unigen offers a line of Unigen Pet and Unigen Beauty active ingredients.

Science Based Ingredients is a diversified nutraceutical sales, marketing and distribution company focused on the development and commercialization of proprietary, innovative and scientifically researched, health-condition specific ingredients. The SBI team develops strong, mutually beneficial, strategic relationships with its customers by providing in-depth industry knowledge and insights, along with proprietary, innovative, science-based nutraceutical solutions improving and enhancing people’s health and wellness.

“Unigen’s commitment to science aligns perfectly with SBI’s focus on science-based-ingredients,” stated Jim Bornhold, SBI President and CEO. “We are excited to bring both Maizinol® for sleep and Univestin® for joint health to the Canadian market. This collaboration further illustrates how SBI delivers on our promise to help people live healthier, happier, and more active lives! We look forward to a highly successful partnership between Unigen and SBI.”

Unigen is equally excited for its new partnership with Science Based Ingredients. “We believe SBI is the right partner in Canada for exclusive distribution of Maizinol® and Univestin®, Unigen’s top tier sleep and joint ingredients,” said Regan Miles, President and CEO. “We see great synergy between our two companies and their mutual focus on delivering exceptional, novel products to the Canadian nutraceutical market.”

About Unigen, Inc.

Unigen discovers, develops, and manufactures proprietary natural-product active ingredients for dietary supplements, cosmetic and personal care products, prescription medical food and botanical drug products. The Company discovers its ingredients through its high-throughput screening PhytoLogix® approach applied to a proprietary well-annotated collection of botanicals and a legacy mining approach applied to botanicals having known medicinal benefits.

Mechanism of action, safety, and efficacy are documented with extensive preclinical in vitro and by human clinical studies. Unigen protects its discoveries with issued patents and patent filings in all major territories and manufactures its products to GMP standards. Unigen commercializes its proprietary ingredients through licensing and ingredient supply alliances with commercial partners engaged in the manufacture, distribution, and marketing of end-products in each of Unigen’s target markets.

About Science Based Ingredients

SBI offers market-ready solutions, based on three pillars – Unique, Innovative, Science-Based – covering numerous health & wellness platforms. These solutions are founded on proprietary, innovative, science-based ingredients supported by well-designed human clinical trials supporting quality, safety and efficacy, and enabling marketers to create safe, effective and captivating natural health products.

UNIGEN MEDIA CONTACT:
Kathy Markham
Marketing Manager
Phone: 253.274.7165
Email: kmarkham@unigen.net

SBI MEDIA CONTACT:
Nathalie Thivierge
Chief Marketing Officer (CMO)
Phone: (905) 955-0087
Email: Nathalie.thivierge@sciencebasedingredients.com

Notice Regarding Forward-Looking Information:
This news release contains forward-looking statements including but not limited to statements regarding the Company’s business, assets or investments, as well other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business and prospects of the Company. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.